DJIA 17,071.22 -41.93 -0.25%
NASDAQ 4,505.85 -6.34 -0.14%
S&P 500 1,977.80 -5.05 -0.25%
market minute promo

276.06 -0.35 (-0.13%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IBB $276.06 -0.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $272.83
Previous Close $276.41
Daily Range $272.62 - $277.91
52-Week Range $191.29 - $280.07
Market Cap $5.5B
P/E Ratio -1,201.78
Dividend (Yield) $0.22 (0.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 832,514
Average Daily Volume 962,903
Current FY EPS $0.00




Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website:

News & Commentary

3 Reasons Actavis plc Stock Could Fall

Shares of specialty drugmaker Actavis have been ripping higher over the past two years. Here are three reasons why this trend could be coming to an end.

Market Notes: Biotech Booms, GoPro Slams Shorts

Here's what the Buzz & Banter team is watching this morning.

Market Notes: Biotech Booms, GoPro Destroys Shorts

Here's what the Buzz & Banter team is watching this morning.

I Agree With Yellen, Sell Biotech Right Now

ETF Preview: ETFs, Futures in the Red As August Durable-Goods Orders Tumble to Record Low

BioShares Plans Two Innovative Biotech ETFs - ETF News And Commentary

You Can Live Without This Biotech CEF

iShares NASDAQ Biotechnology Index Fund (IBB) Ex-Dividend Date Scheduled for September 24, 2014

3 Hot Ways to Play the Biotechnology Bonanza

Bulls Go Down Swinging, Refusing To Give Up Much Ground

See More IBB News...

IBB's Top Competitors

IBB $276.06 (-0.13%)
Current stock: IBB
VTA $12.32 (-0.65%)
Current stock: VTA
NCV $9.52 (-2.16%)
Current stock: NCV
ZTR $13.89 (0.14%)
Current stock: ZTR